Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Adenoviral vector-based respiratory syncytial virus (RSV) vaccine

Adenoviral vector-based respiratory syncytial virus (RSV) vaccine

US Patent 9580476 · Granted Feb 28, 2017

Estimated economic value: $539,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human papillomavirus vaccines and uses of the same2025
Hepatitis B vaccines and uses of the same2025
Hepatitis B vaccines and uses of the same2023
Simian (gorilla) adenovirus or adenoviral vectors and methods of use2022
Simian (gorilla) adenovirus or adenoviral vectors and methods of use2022
Simian (gorilla) adenovirus or adenoviral vectors and methods of use2022
Adenoviral vector encoding human atonal homolog-1 (HATH1)2022
Adenovectors for delivery of therapeutic genetic material into T cells2021
Affenadenovirus (gorilla) or adenoviral vectors and methods of use2021
Affenadenovirus (gorilla) or adenoviral vectors and methods of use2021
Affenadenovirus (gorilla) or adenoviral vectors and methods of use2021
Modified serotype 28 adenoviral vectors2021